A generic image of a person on their laptop
Markets

Enfamil Tests Come Back Negative; Mead Johnson Nutrition Shares Rally (MJN)

Pediatric nutrition specialist Mead Johnson Nutrition Co. ( MJN ) on Tuesday saw its shares jumping higher in premarket trading, following a report of no bacteria found in its Enfamil baby formula.

A release Sunday morning noted that after "a new round of rigorous testing," the formula has been declared safe for consumption. Last week, MJN shares were trounced following a scare that its Enfamil PREMIUM Newborn powdered formula could have been tainted with the Cronobacter (Enterobacter sakazakii) bacteria.

Major retailers like Wal-Mart ( WMT ), Safeway ( SWY ), and Walgreen ( WAG ) all voluntarily pulled the formula from store shelves amid the scare.

Mead Johnson shares rose $3.34, or +5.1%, in premarket trading Tuesday.

The Bottom Line

Shares of Mead Johnson Nutrition ( MJN ) have a 1.59% dividend yield, based on Friday's closing stock price of $65.29. The stock has technical support in the $61-$65 price area. If the stock can firm up, we see overhead resistance around the all-time highs of $76-$77 a share.

Mead Johnson Nutrition Co. ( MJN ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Created by Dividend.com


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

Stocks

Latest Markets Videos